Skip to content

Dr. Cornelis Natasha

Active
Private limited companyfounded 201511 yrs activeTorhoutsesteenweg 147, 8210 Zedelgem, BelgiumKBO/BCE: BE 0598.810.593

Dr. Cornelis Natasha has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €695k and a net result of €113k. Equity is growing by ~11.8% per year across the filed fiscal years. Its solvency ranks better than 49% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Checked score

Score 2025
90 / 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability81▼-4
Solvency88▼-12
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 2.4 against 8.78 in 2024; short-term debt: 28.4% and cash: 63.1% of total assets), and 37.2% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
62.8%
Return on assets
10.2%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 11 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
2 d early
2024
27 d late
2023
49 d late
2022
77 d late
2021
5 d late
2020
5 d early
2019
4 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
23-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€695k▼ 14.9%
2024 · €817k
2018: €283k 2019: €385k 2020: €518k 2021: €632k 2022: €765k 2023: €682k 2024: €817k
2018 → 2025
Total assets
€1.11M▲ 8.6%
2024 · €1.02M
2018: €374k 2019: €802k 2020: €900k 2021: €990k 2022: €1.13M 2023: €1.04M 2024: €1.02M
2018 → 2025
Net result
€113k▼ 17.0%
2024 · €136k
2018: €136k 2019: €102k 2020: €133k 2021: €157k 2022: €203k 2023: €53k 2024: €136k
2018 → 2025
Working capital
€439k▼ 21.3%
2024 · €558k
2018: €177k 2019: €272k 2020: €343k 2021: €453k 2022: €581k 2023: €421k 2024: €558k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€632k-€765k▲ 21.0%€682k▼ 10.9%€817k▲ 19.9%€695k▼ 14.9%
Operating result€228k-€297k▲ 29.8%€74k▼ 74.9%€194k▲ 161%€158k▼ 18.5%
Net result€157k-€203k▲ 29.1%€53k▼ 73.8%€136k▲ 156%€113k▼ 17.0%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€100k€200k€300kOperating result 2021: €228k€228kNet result 2021: €157k€157kOperating result 2022: €297k€297kNet result 2022: €203k€203kOperating result 2023: €74k€74kNet result 2023: €53k€53kOperating result 2024: €194k€194kNet result 2024: €136k€136kOperating result 2025: €158k€158kNet result 2025: €113k€113k20212022202320242025
The operating result falls in 2025; 2025 is 19% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.11M
Fixed assets €355k▼ 9.1%
Current assets €753k▲ 19.6%
Equity and liabilities €1.11M
Equity €695k▼ 14.9%
Debt €413k▲ 104%
The debt ratio rises from 19.8% to 37.2%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€193k
2024 · €229k
Cash flow
€148k
2024 · €171k
Solvency
62.8%
2024 · 80.2%
Current ratio
2.40
2024 · 8.78
Quick ratio
2.40
2024 · 8.78
Debt / equity
0.59
2024 · 0.25
ROE
16.2%
2024 · 16.6%
ROA
10.2%
2024 · 13.3%
Interest coverage
66.49
2024 · 166.70
Debt
€413k
2024 · €202k
Debt ≤ 1 year
€314k
2024 · €72k
Debt > 1 year
€98k
2024 · €131k
Income taxes
€46k
2024 · €57k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.02M€1.11M
Fixed assets21/28€390k€355k
Tangible fixed assets22/27€390k€355k
Land and buildings22€324k€314k
Plant, machinery and equipment23€2k€2k
Furniture and vehicles24€48k€36k
Other tangible fixed assets26€16k€3k
Current assets29/58€629k€753k
Amounts receivable within one year40/41€110k-
Other amounts receivable41€110k-
Current investments50/53€100k-
Cash at bank and in hand54/58€373k€699k
Deferred charges and accrued income490/1€47k€53k
Equity and liabilities
Total equity and liabilities10/49€1.02M€1.11M
Equity10/15€817k€695k
Contributions10/11€12k€12k=
Reserves13€785k€663k
Distributable reserves133€785k€663k
Profit (loss) carried forward14€19k€19k=
Amounts payable17/49€202k€413k
Amounts payable after more than one year17€131k€98k
Financial debts170/4€131k€98k
Amounts payable within one year42/48€72k€314k
Current portion of amounts payable after more than one year42€32k€32k
Trade debts44€5k€3k
Suppliers440/4€5k€3k
Taxes, remuneration and social security45€10k€16k
Taxes450/3€7k€13k
Remuneration and social security454/9€3k€3k
Other amounts payable47/48€24k€263k
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€35k€35k
Other operating charges640/8€2k€1k
Gross operating margin9900€231k€195k
Operating profit (loss)9901€194k€158k
Financial income75/76B€129€4k
Recurring financial income75€129€4k
Financial charges65/66B€1k€3k
Recurring financial charges65€1k€3k
Profit (loss) for the period before taxes9903€193k€159k
Income taxes67/77€57k€46k
Profit (loss) for the period9904€136k€113k
Profit (loss) for the period to be appropriated9905€136k€113k
Appropriation of the result
Profit (loss) to be appropriated9906€155k€132k
Profit (loss) brought forward from the previous period14P€19k€19k=
Transfer from equity791/2-€235k
Transfer to equity691/2€136k€113k
To other reserves6921€136k€113k
Profit to be distributed694/7-€235k
Return on contributions (dividend)694-€235k

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
27-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
31-12
Financial Liquidity triplescurrent ratio 8.78
Current ratio from 3.15 to 8.78; short-term debt falls from €196k to €72k.
18-09
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 49 days late
2023
31-12
Financial Weakest financial yearnet €53k ▼73.8%
Net result drops to €53k, the lowest in the series; recovery starts the following year.
16-10
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 77 days late
2022
31-12
Financial Highest result since 2018net €203k ▲29.1%
Operating result €297k, net result €203k, both a record.
05-08
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 5 days late
2021
26-07
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial Equity above €500kEq €518k ▲34.5%
3 profitable years in a row build equity to €518k.
27-07
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
29-07
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2018
26-07
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2017
11-07
NBB filing Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zedelgem · 1 establishment unit since 2015
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Torhoutsesteenweg 1478210 Zedelgem
Ground area
974 m²
Building footprint
237 m²
Volume, LiDAR
1,539 m³
Parcel 31040F1518/00K000, Flanders · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Cornelis Natasha
Torhoutsesteenweg 147, 8210 ZedelgemManufacture of basic pharmaceutical products and pharmaceutical preparations
since 20152.239.712.479
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31040F1518/00K000 Flanders 974 m² 1 · 237 m² 9.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,162 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded19-02-2015
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 11 filingsAddress and cadastre registers

Data from official sources, last processed on 23-09-2026. Scores and ratios are computed by Checked and are not a credit decision.